Binding thermodynamics at A1 and A(2a) adenosine receptors

Life Sciences

Volumn 59, Issue 17, 1996, Pages 1373-1388

  Borea, Pier Andrea ^a   Dalpiaz, A ^a   Varani, K ^a   Gessi, S ^a   Gilli, G ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

adenosine; binding thermodynamics; enthalpy entropy compensation; thermodynamic discrimination

Indexed keywords

2 ANILINOADENOSINE; 2 CHLOROADENOSINE; 2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 6 N BENZYLADENOSINE; 6 N CYCLOPENTYLADENOSINE; 6 N METHYLADENOSINE; 6 N PHENYLADENOSINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; 8 CYCLOPENTYLTHEOPHYLLINE; ADENOSINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; CAFFEINE; CYCLOHEXYLADENOSINE; ENPROFYLLINE; ISOBUTYLMETHYLXANTHINE; PARTIAL AGONIST; PHENYLISOPROPYLADENOSINE; SOLVENT; THEOBROMINE; THEOPHYLLINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; XANTHINE DERIVATIVE; ADENOSINE RECEPTOR; LIGAND;

BINDING AFFINITY; BRAIN; DRUG ACTIVITY; ENTHALPY; ENTROPY; MODEL; NONHUMAN; RECEPTOR BINDING; RECEPTOR INTRINSIC ACTIVITY; REVIEW; STRUCTURE ACTIVITY RELATION; THERMODYNAMICS; ANIMAL; CHEMISTRY; DRUG EFFECT; METABOLISM; PROTEIN BINDING;

ANIMALS; LIGANDS; PROTEIN BINDING; RECEPTORS, PURINERGIC P1; THERMODYNAMICS;

EID: 0029684422     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/0024-3205(96)00311-6     Document Type: Short Survey

References (52)

1. 1. G. GILLI and P.A. BOREA, The Application of Charge-Density Research to Chemistry and Drug Design, G.A. Jeffrey and J.F. Piniella (Eds), 241-286, Plenum Publishing, New York (1991).
2. 2. G.A. WEILAND, K.P. MINNEMAN and P.B. MOLINOFF, Nature 281 114-117 (1979).
3. 3. G.A. WEILAND, K.P. MINNEMAN and P.B. MOLINOFF, Molecular Pharmacology 18 341-347 (1980).
4. 4. M.L. CONTRERAS, B.B. WOLFE and P.B. MOLINOFF, J. Pharmacol. Exp. Ther. 237 154-164 (1986).
5. 5. M.L. CONTRERAS, B.B. WOLFE and P.B. MOLINOFF, J. Pharmacol. Exp. Ther. 273 165-172 (1986).
6. 6. F. BREE, N. EL TAYAR, H. VAN DE WATERBEEMD, B. TESTA and J.P. TILLEMENT, Journal of Receptor Research 6 387-409 (1986).
7. 7. I. JAKAYANAGE, M. OGESHIMA and K. KOIKE, Gen. Pharm. 21 303-307 (1990).
8. 8. A. MIKLAVC, D. KORJAN, J. MAURI, J. KOLLER and D. HADZ, Biochem Pharmacol. 40 663-669 (1990).
9. 9. K.M.M. MURPHY and S.N. SNYDER, Mol. Pharmacol. 22 250-257 (1982).
10. 10. M.J. LOHSE, N. LENSCHOW and U. SCHWABE, Mol. Pharmacol. 26 1-9 (1984).
11. 11. P.A. BOREA, K. VARANI, V. MALAGUTI and G. GILLI, J. Pharm. Pharmacol. 43 866-868 (1991).
12. 12. P.A. BOREA, K. VARANI, L. GUERRA, P. GILLI and G. GILLI, Mol. Neuropharmacol. 2 273-281 (1992).
13. 13. P.A. BOREA, K. VARANI, A. DALPIAZ, A. CAPUZZO, E. FABBRI and A.P. IJZERMAN, Eur. J. Pharmacol. (Mol. Pharmacol. Section) 267 55-61 (1994).
14. 14. A. DALPIAZ, K. VARANI, P.A. BOREA, C. MARTINI, G. CHIELLINI and A. LUCACCHINI, Biochimica et Biophysica Acta 1267 145-151 (1995).
15. 15. C. MAKSAY, Mol. Pharmacol. 46 336-390 (1994).
16. 16. P.A. BOREA, A. DALPIAZ, K. VARANI, L. GUERRA and G. GILLI, Biochem. Pharmacol. 49 461-469 (1995).
17. 17. P.A. BOREA, A. DALPIAZ, S. GESSI and G. GILLI, Eur. J. Pharmacol. 1996, in press.
18. 18. D.B. BYLUND and H.I. YAMAMURA, Methods in Neurotransmitter Receptor Analysis, H.I. Yamamura, S.J. Enna and M.J. Kuhar (Eds), 1-36, Raven Press, New York (1990).
19. 19. A. DALPIAZ, S. GESSI, P.A. BOREA and G. GILLI, Life Sci. 57 PL 141-146 (1995).
20. 20. R. HITZEMANN, M. MURPHY and J. CURREL, Eur. J. Pharm. 108 171-177 (1985).
21. 21. P.A. BOREA, G.M. BERTELLI and G. GILLI, Eur. J. Pharm. 146 247-252 (1988).
22. 22. K.D. WILD, F. PORRECA, H.I. YAMAMURA and R.B. RAFFA, Proc. Natl. Acad. Sci. USA 91 12018-12021 (1994).
23. 23. R.L. KOCHMAN and J.D. HIRSCH, Mol. Pharmacol. 22 325-341 (1982).
24. 24. A. DOBLE, J. Neurochem. 40 1605-1612 (1983).
25. 25. G.J. KILPATRICK, N. EL TAYAR, H. VAN DE WATERBEEMD, I. JENNER, B. TESTA and C.D. MARSDEN, Mol. Pharmacol. 30 226-234 (1986).
26. 26. E.P. DUARTE, C.R. OLIVEIRA and A.P. CARVALHO, Eur. J. Pharmacol. 147 277-289 (1988).
27. 27. B. TESTA, P. JENNER, G.J. KILPATRICK, N. EL TAYAR, H. VAN DE WATERBEEMD, C. D. MARSDEN, Biochem. Pharmacol. 36 4041-4046 (1987).
28. 28. R. HITZEMANN, Trends Pharmacol. Sci. 9 408-411 (1988).
29. 29. R.B. RAFFA and F. PORRECA, Life Sci. 44 245-258 (1989).
30. 30. Y.C. CHENG and W.H. PRUSOFF, Biochem. Pharmacol. 22 3099-3108 (1973).
31. 31. J.P. OSBORNE, G. PALUMBO, H.B. BREWER and H. EDELHOCH, Biochemistry 15 317-320 (1976).
32. 32. P. GILLI, V. FERRETTI, G. GILLI and P.A. BOREA, J. Phys. Chem. 98 1515-1518 (1994).
33. 33. B.B. FREDHOLM, M.P. ABBRACCHIO, G. BURNSTOCK, J. W. DALY, T.K. HARDEN, R.A. JACOBSON, P. LEFF and M. WILLIAMS, Pharmacological Reviews 46 143-156 (1994).
34. 34. M.F. HIBERT, S. TRUMPP-KALLMEYER, A. BRUINVELS and J. HOFLACK, Mol. Pharmacol. 40 8-15 (1991).
35. 35. D. VAN CALKER, M. MULLER and B. HAMPRECHT, Nature (London) 276 839-841 (1978).
36. 36. C. LONDOS, D.M.F. COOPER and J. WOLFF, Proc. Natl. Acad. Sci. USA 77 2551-2554 (1980).
37. 37. Q.Y. ZHOU, C. LI, M.E. OLAH, R.A. JOHSON, G.L. STILES and O. CISELLI, Proc. Natl. Acad. Sci. USA 89 7432-7436 (1992).
38. 38. M.G. COLLIS and S.M.O. HOURANI, Trends Pharmacol. Sci. 14 360-366 (1993).
39. 39. K.P. SCHOLZ and R.J. MILLER, J. Physiol. (Lond.) 435 373-393 (1991).
40. 40. M.D. TAYLOR, W.H. MOOS, H.W. HAMILTON, D.J. SROTEK, W.C. PATT, E.W. BADGER, J.A. BRISTOL, R.F. BRUNS, T.G. HEFFNER and T.E. MERZ, J. Med. Chem. 29 346-353 (1986).
41. 41. M.J. LOHSE, V. LENSCHOW and U. SCHWABE, Eur.J.Pharmacol. 156 157-160 (1988).
42. 42. A.P. IJZERMAN, E.M. VAN DER WENDEN, J. K. VON FRIJTAGDRABBE KÜNZEL, R.A.A. MATHÔT, M. DANHOF, P.A. BOREA and K. VARANI, Naunyn-Schmiederberg's Arch. Pharmacol. 350 638-645 (1994).
43. 43. P.A. BOREA, A. DALPIAZ, A.P. IJZERMAN, E.M. VAN DER WENDEN, R.A.A. MATHÔT, M. DANHOF, Drug Dev. Res. 31 251 (1994).
44. 44. T.P. KENAKIN, Pharmacologic Analysis of Drug-Receptor Interaction, Raven Press, New York (1987).
45. 45. P. TAYLOR and P.A. INSELL. Principles of Drug Action, third edition, W.B. Pratt and P. Taylor (Eds), 1-102, Churchill Livingstone, Edinburgh (1990).
46. 46. P.J.M. VAN GALEN, G.L. STILES, G. MICHAELS and K.A. JACOBSON, Med. Res. Rev. 12 423-471 (1992).
47. 47. K.A. JACOBSON, G.L. STILES and J. XIAO-DO, Mol. Pharmacol. 42 123-133 (1992).
48. 48. J.M. STURTEVANT, Proc. Natl.Acad. Sci. USA 74 2236-(1977).
49. 49. G.T. EDSALL and H. GUTFREUND, Biothermodynamics, John Wiley & Sons, New York (1983).
50. 50. M. WULBROECK, E. VAN OBBERGHEN, P. De MEYTS, J. Biol. Chem. 254 7736-7740 (1979).
51. 51. J.E. LEFFER and E. GRUNWALD, Rates and Equilibria of Organic Reactions, John Wiley & Sons, New York (1963).
52. 52. E. GRUNWALD and C. STEEL, J. Am. Chem. Soc. 117 5687-5692 (1995).